RARA CRAFT DATABASE for FDA Medical Devices
510(k)K253893

FDA DEVICE FACTS

Harmony Referral System with Harmony OCT Viewer (Octave)

Topcon Healthcare Solutions EMEA Oy

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJune 4, 2026PRODUCT CODENFJCLINICAL AREARadiology

Indications for use

Harmony Referral System is a software platform for importing, processing, viewing, measuring, and storing clinical images and videos, and for managing and communicating patient data, diagnostic and clinical information, and reports from ophthalmic diagnostic instruments through direct instrument connections or computerized networks. It does not interpret information or provide treatment recommendations. The optional Harmony OCT Viewer module processes, displays, analyzes, and measures clinical optical-coherence-tomography and fundus images from any OCT acquisition device in conjunction with Harmony Referral System as a medical-image communication system. It aids diagnosis and monitoring through quantitative assessment of ocular anatomy for various diseases, but does not itself diagnose, treat, actively monitor, or recommend treatment. For Topcon OCT devices, it uses reference databases from the original acquisition device to quantitatively compare results with normal subjects.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 22, 2026